Markets:

Overview

News

Currencies

International

Treasuries

Merck & Co (NY:MRK)

116.25 +0.82 (+0.71%)

Streaming Delayed Price Updated: 2:52 PM EDT, Mar 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

99 100 Next >

Inflation Isn’t Going Away, But These Sectors Don’t Care ↗

March 13, 2025

The CPI and PPI releases this week came in more or less at estimates - nothing to alarm the talking heads, anyway. They show inflation slowing down but not receding.

Via Talk Markets

How Do Investors Really Feel About Merck & Co? ↗

March 12, 2025

Via Benzinga

Merck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025 ↗

March 12, 2025

Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for mid-2025.

Via Benzinga

Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral Suppression at Week 48

March 12, 2025

From Merck & Co., Inc.

Via Business Wire

Merck & Co Unusual Options Activity For March 10 ↗

March 10, 2025

Via Benzinga

Spotlight on Merck & Co: Analyzing the Surge in Options Activity ↗

March 04, 2025

Via Benzinga

Merck Injects $1 Billion To Expand Vaccine Production In US ↗

March 11, 2025

Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and research investments.

Via Benzinga

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.

March 11, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

March 11, 2025

Moderna stock has fallen to levels not seen in 5 years, but the CEO just spent $5 million buying stock in the open market underscoring his optimism for gains.

Via MarketBeat

Merck Unveils New Facility to Increase Vaccine Production Capacity

March 11, 2025

From Merck & Co., Inc.

Via Business Wire

Decoding Merck & Co's Options Activity: What's the Big Picture? ↗

February 27, 2025

Via Benzinga

MERCK & CO., INC. (NYSE: MRK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Merck & Co., Inc. Investors of Upcoming Deadline

March 10, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

Institutional Investors Bet $1B on These 4 Stocks—Should You?

March 09, 2025

Institutional investors snapped up at least $1 billion in shares of each of these four companies in Q4 of 2024 - should you buy as well?

Via MarketBeat

3 Magnificent S&P 500 Dividend Stocks Down 20% to 63% to Buy and Hold Forever ↗

March 09, 2025

Great investments are even better and more fruitful when you can buy them at a discount.

Via The Motley Fool

Topics Stocks

5 Top Stocks to Buy for March ↗

March 08, 2025

These 5 stocks look rather intriguing at current levels.

Via The Motley Fool

In a market where value is scarce, MERCK & CO. INC. (NYSE:MRK) offers a refreshing opportunity with its solid fundamentals. ↗

March 08, 2025

Discover MERCK & CO. INC., an undervalued stock. NYSE:MRK showcases solid financial health and profitability while maintaining an appealing valuation.

Via Chartmill

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.

March 08, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug ↗

March 06, 2025

HC Wainwright initiates coverage on ImmunityBio with a Buy rating, citing Anktiva's growth potential. The firm projects $4.3 billion in sales, up from $137M in 2025.

Via Benzinga

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FMC, Elastic, Intellia, and Merck and Encourages Investors to Contact the Firm

March 04, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, A LEADING NATIONAL FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK

March 04, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

March 04, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bristol-Myers Squibb (NYSE:BMY) and the best...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Pfizer CEO Says Company May Shift Overseas Manufacturing To US Amid Looming Tariff Threats: 'Will The Trump Administration Co-Invest', Asks Analyst ↗

March 04, 2025

In light of potential tariff threats from President Donald Trump, Pfizer Inc.'s (PFE.N) CEO Albert Bourla has suggested the possibility of shifting the company's overseas manufacturing to its U.S....

Via Benzinga

Topics Government World Trade

These S&P 500 Stocks Have Low P/E Ratios — Time to Buy?

March 03, 2025

This article covers three stocks included in the S&P 500 which are showing exceptionally low P/E ratios of 20 or less, indicating potential buys.

Via MarketBeat

Topics Stocks

MERCK & CO., INC. (NYSE: MRK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Merck & Co., Inc. Investors of Upcoming Deadline

March 03, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

These Vanguard ETFs Show Where the Smart Money Is Moving Now ↗

March 03, 2025

Via The Motley Fool

Topics ETFs

Deadline Alert: Merck & Co (MRK) Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

February 28, 2025

From Glancy Prongay & Murray LLP

Via Business Wire

4 Sectors That Thrive When Inflation Runs Hot

February 28, 2025

Sticky inflation and higher-for-longer interest rates is causing a rotation out of technology stocks, here are four sectors for investors hunting for value

Via MarketBeat

Topics Economy World Trade

Deadline Approaching: Merck & Co (MRK) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith

February 27, 2025

From Law Offices of Howard G. Smith

Via Business Wire

NovoCure Q4 EPS Misses, Revenue Matches ↗

February 27, 2025

NovoCure reported a solid jump in revenue, but earnings fell short due to rising costs and adoption challenges.

Via The Motley Fool

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK

February 26, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.